AAPL335.21+5.81 (+1.76%) ▲|ABBV262.85-0.44 (-0.17%) ▼|ABT98.94-2.02 (-2.00%) ▼|ACN183.18+6.06 (+3.42%) ▲|ADBE240.42+7.25 (+3.11%) ▲|AMAT514.21+2.20 (+0.43%) ▲|AMD612.80+5.23 (+0.86%) ▲|AMGN422.03-1.61 (-0.38%) ▼|AMT163.99-1.57 (-0.95%) ▼|AMZN250.14+3.47 (+1.40%) ▲|AVGO351.88-3.22 (-0.91%) ▼|AXP304.26-1.15 (-0.37%) ▼|BA186.40-1.28 (-0.68%) ▼|BAC54.57-0.39 (-0.71%) ▼|BKNG162.83+0.49 (+0.30%) ▲|BLK1,060.33-7.61 (-0.71%) ▼|BMY62.84-0.03 (-0.04%) ▼|BNY145.10-1.89 (-1.28%) ▼|BRK-B498.80-3.55 (-0.71%) ▼|C129.99-0.81 (-0.62%) ▼|CAT813.14-13.50 (-1.63%) ▼|CL85.64-0.83 (-0.95%) ▼|CMCSA21.87+0.27 (+1.23%) ▲|COF193.92-2.55 (-1.30%) ▼|COP125.35-0.09 (-0.07%) ▼|COST912.33-12.26 (-1.33%) ▼|CRM229.72+4.41 (+1.96%) ▲|CSCO107.93+0.99 (+0.93%) ▲|CVS86.02-1.08 (-1.24%) ▼|CVX205.10+0.72 (+0.35%) ▲|DE673.61-5.27 (-0.78%) ▼|DHR222.09-3.62 (-1.60%) ▼|DIS105.55+0.14 (+0.13%) ▲|DUK114.29+0.08 (+0.07%) ▲|EMR155.66-1.58 (-1.00%) ▼|FDX285.48-1.99 (-0.69%) ▼|GD332.51+0.17 (+0.05%) ▲|GE313.80-4.09 (-1.29%) ▼|GEV950.93-11.56 (-1.20%) ▼|GILD149.35-1.93 (-1.28%) ▼|GM77.27-3.20 (-3.98%) ▼|GOOG338.84+1.52 (+0.45%) ▲|GOOGL341.74+0.82 (+0.24%) ▲|GS902.61-13.63 (-1.49%) ▼|HD284.50-3.54 (-1.23%) ▼|HON211.84+1.71 (+0.81%) ▲|IBM220.48+0.49 (+0.22%) ▲|INTC120.23+4.30 (+3.71%) ▲|INTU275.92+7.89 (+2.94%) ▲|ISRG407.28-4.91 (-1.19%) ▼|JNJ265.57-2.00 (-0.75%) ▼|JPM331.74-3.24 (-0.97%) ▼|KO86.24-0.60 (-0.69%) ▼|LIN476.59+3.22 (+0.68%) ▲|LLY1,165.13-19.50 (-1.65%) ▼|LMT509.85-2.36 (-0.46%) ▼|LOW185.01-2.25 (-1.20%) ▼|LRCX330.04+6.18 (+1.91%) ▲|MA553.44-10.15 (-1.80%) ▼|MCD231.37-2.61 (-1.12%) ▼|MDLZ57.92-0.89 (-1.51%) ▼|MDT86.70-0.39 (-0.45%) ▼|META727.07-11.72 (-1.59%) ▼|MMM164.91-3.58 (-2.12%) ▼|MO67.54-1.18 (-1.72%) ▼|MRK146.05-3.23 (-2.16%) ▼|MS188.89-3.88 (-2.01%) ▼|MSFT512.85+3.89 (+0.76%) ▲|MU1,063.07-2.01 (-0.19%) ▼|NEE76.04+0.15 (+0.20%) ▲|NFLX69.64-0.66 (-0.94%) ▼|NKE35.38-0.47 (-1.30%) ▼|NOW134.22+4.28 (+3.29%) ▲|NVDA229.46+2.25 (+0.99%) ▲|ORCL137.37-0.43 (-0.31%) ▼|PEP126.88-1.81 (-1.41%) ▼|PFE28.61-0.12 (-0.40%) ▼|PG145.73-2.59 (-1.75%) ▼|PLTR187.35+0.38 (+0.20%) ▲|PM192.07-1.84 (-0.95%) ▼|QCOM184.39+0.29 (+0.16%) ▲|RTX186.15-0.80 (-0.43%) ▼|SBUX93.96-1.47 (-1.54%) ▼|SCHW97.74-1.36 (-1.37%) ▼|SO82.92-0.53 (-0.64%) ▼|SPG200.65-3.63 (-1.78%) ▼|T24.44-0.04 (-0.16%) ▼|TMO678.39-1.22 (-0.18%) ▼|TMUS163.60+0.62 (+0.38%) ▲|TSLA354.14+1.30 (+0.37%) ▲|TXN280.09-1.60 (-0.57%) ▼|UBER68.51-0.85 (-1.23%) ▼|UNH367.31-7.63 (-2.04%) ▼|UNP272.11-2.04 (-0.74%) ▼|UPS93.43-0.50 (-0.53%) ▼|USB57.77+0.17 (+0.30%) ▲|V359.50-6.38 (-1.74%) ▼|VZ45.90-0.08 (-0.17%) ▼|WFC80.11-0.37 (-0.46%) ▼|WMT103.92-2.88 (-2.70%) ▼|XOM162.88+1.53 (+0.95%) ▲|AAPL335.21+5.81 (+1.76%) ▲|ABBV262.85-0.44 (-0.17%) ▼|ABT98.94-2.02 (-2.00%) ▼|ACN183.18+6.06 (+3.42%) ▲|ADBE240.42+7.25 (+3.11%) ▲|AMAT514.21+2.20 (+0.43%) ▲|AMD612.80+5.23 (+0.86%) ▲|AMGN422.03-1.61 (-0.38%) ▼|AMT163.99-1.57 (-0.95%) ▼|AMZN250.14+3.47 (+1.40%) ▲|AVGO351.88-3.22 (-0.91%) ▼|AXP304.26-1.15 (-0.37%) ▼|BA186.40-1.28 (-0.68%) ▼|BAC54.57-0.39 (-0.71%) ▼|BKNG162.83+0.49 (+0.30%) ▲|BLK1,060.33-7.61 (-0.71%) ▼|BMY62.84-0.03 (-0.04%) ▼|BNY145.10-1.89 (-1.28%) ▼|BRK-B498.80-3.55 (-0.71%) ▼|C129.99-0.81 (-0.62%) ▼|CAT813.14-13.50 (-1.63%) ▼|CL85.64-0.83 (-0.95%) ▼|CMCSA21.87+0.27 (+1.23%) ▲|COF193.92-2.55 (-1.30%) ▼|COP125.35-0.09 (-0.07%) ▼|COST912.33-12.26 (-1.33%) ▼|CRM229.72+4.41 (+1.96%) ▲|CSCO107.93+0.99 (+0.93%) ▲|CVS86.02-1.08 (-1.24%) ▼|CVX205.10+0.72 (+0.35%) ▲|DE673.61-5.27 (-0.78%) ▼|DHR222.09-3.62 (-1.60%) ▼|DIS105.55+0.14 (+0.13%) ▲|DUK114.29+0.08 (+0.07%) ▲|EMR155.66-1.58 (-1.00%) ▼|FDX285.48-1.99 (-0.69%) ▼|GD332.51+0.17 (+0.05%) ▲|GE313.80-4.09 (-1.29%) ▼|GEV950.93-11.56 (-1.20%) ▼|GILD149.35-1.93 (-1.28%) ▼|GM77.27-3.20 (-3.98%) ▼|GOOG338.84+1.52 (+0.45%) ▲|GOOGL341.74+0.82 (+0.24%) ▲|GS902.61-13.63 (-1.49%) ▼|HD284.50-3.54 (-1.23%) ▼|HON211.84+1.71 (+0.81%) ▲|IBM220.48+0.49 (+0.22%) ▲|INTC120.23+4.30 (+3.71%) ▲|INTU275.92+7.89 (+2.94%) ▲|ISRG407.28-4.91 (-1.19%) ▼|JNJ265.57-2.00 (-0.75%) ▼|JPM331.74-3.24 (-0.97%) ▼|KO86.24-0.60 (-0.69%) ▼|LIN476.59+3.22 (+0.68%) ▲|LLY1,165.13-19.50 (-1.65%) ▼|LMT509.85-2.36 (-0.46%) ▼|LOW185.01-2.25 (-1.20%) ▼|LRCX330.04+6.18 (+1.91%) ▲|MA553.44-10.15 (-1.80%) ▼|MCD231.37-2.61 (-1.12%) ▼|MDLZ57.92-0.89 (-1.51%) ▼|MDT86.70-0.39 (-0.45%) ▼|META727.07-11.72 (-1.59%) ▼|MMM164.91-3.58 (-2.12%) ▼|MO67.54-1.18 (-1.72%) ▼|MRK146.05-3.23 (-2.16%) ▼|MS188.89-3.88 (-2.01%) ▼|MSFT512.85+3.89 (+0.76%) ▲|MU1,063.07-2.01 (-0.19%) ▼|NEE76.04+0.15 (+0.20%) ▲|NFLX69.64-0.66 (-0.94%) ▼|NKE35.38-0.47 (-1.30%) ▼|NOW134.22+4.28 (+3.29%) ▲|NVDA229.46+2.25 (+0.99%) ▲|ORCL137.37-0.43 (-0.31%) ▼|PEP126.88-1.81 (-1.41%) ▼|PFE28.61-0.12 (-0.40%) ▼|PG145.73-2.59 (-1.75%) ▼|PLTR187.35+0.38 (+0.20%) ▲|PM192.07-1.84 (-0.95%) ▼|QCOM184.39+0.29 (+0.16%) ▲|RTX186.15-0.80 (-0.43%) ▼|SBUX93.96-1.47 (-1.54%) ▼|SCHW97.74-1.36 (-1.37%) ▼|SO82.92-0.53 (-0.64%) ▼|SPG200.65-3.63 (-1.78%) ▼|T24.44-0.04 (-0.16%) ▼|TMO678.39-1.22 (-0.18%) ▼|TMUS163.60+0.62 (+0.38%) ▲|TSLA354.14+1.30 (+0.37%) ▲|TXN280.09-1.60 (-0.57%) ▼|UBER68.51-0.85 (-1.23%) ▼|UNH367.31-7.63 (-2.04%) ▼|UNP272.11-2.04 (-0.74%) ▼|UPS93.43-0.50 (-0.53%) ▼|USB57.77+0.17 (+0.30%) ▲|V359.50-6.38 (-1.74%) ▼|VZ45.90-0.08 (-0.17%) ▼|WFC80.11-0.37 (-0.46%) ▼|WMT103.92-2.88 (-2.70%) ▼|XOM162.88+1.53 (+0.95%) ▲|
23.7 C
New York
Wednesday, September 30, 2026

Tag: content

newssourceFORcompanyinformationcontent1releasesmarket

MountBay Energy Unlocks Microbial Biofilm Technology to Revolutionize Battery Longevity

NEW YORK, June 21, 2025 (GLOBE NEWSWIRE) -- MountBay Energy has unveiled groundbreaking research on microbial biofilms that could redefine the future of grid-scale energy storage. The study, led by founder Vrushabhraj Tanawade, introduces a bio-integrated insulation method using thermophilic and mesophilic microbial consortia to regulate heat inside battery modules. The results are striking: up to a 22% reduction in internal temperature and a 30% improvement in carbon lifecycle efficiency.

Fed’s ‘Wait and See’—Translation: ‘Cross Fingers and Hope for the Best’

The Federal Reserve, in its infinite wisdom, has decided to cling to its current interest rate policy, holding steady for yet another meeting. This...

Changsha uses engineering expertise to engage in BRI

BEIJING, June 21, 2025 /PRNewswire/ -- A report from China Daily Engineering machinery is a specialty of Changsha in Central China's Hunan province and a...

Disney’s Digital Dystopia: Meet Wall-E, Now Packing Heat

Midjourney’s latest AI tool churns out videos featuring Disney and Universal’s copyrighted characters, including a gun-toting Wall-E. If you think this is new, it’s...

DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years

Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France, June 21, 2025 /PRNewswire/ -- DDB Worldwide, part...

DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years

Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France, June 20, 2025 /CNW/ -- DDB Worldwide, part...

DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years

Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France, June 20, 2025 /PRNewswire/ -- DDB Worldwide, part...

enCore Energy Announces Filing of Early Warning Report

NASDAQ:EUTSXV:EUwww.encoreuranium.com  DALLAS, June 20, 2025 /CNW/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announces that it has...

enCore Energy Announces Filing of Early Warning Report

NASDAQ:EUTSXV:EUwww.encoreuranium.com  DALLAS, June 20, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announces that it has...

Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025

Bagsværd, Denmark, 20 June 2025 – Novo Nordisk announces subcutaneous amycretin data being presented at the American Diabetes Association (ADA) 85th Scientific Sessions in Chicago, US.1 Full results of two clinical trials evaluating the safety, tolerability and weight loss potential of subcutaneous and oral amycretin in people with overweight or obesity were published today in The Lancet medical journal.1,3 Amycretin is the first treatment that combines GLP-1 and amylin receptor agonism biology in a single molecule.

Embrace Active Site Care Patch Becomes First Medical Device Clinically Proven to Significantly Improve Lipohypertrophy (LH) in Insulin-Using Diabetes Patients

Findings from 16-week trial of novel compression patch will be shared for the first time at the 85th Scientific Sessions of the American Diabetes...

Novo Nordisk advances early-stage obesity medication, amycretin, to phase 3 clinical development based on early-phase clinical trial results in people with obesity or excess...

Both subcutaneous and oral formulations will advance straight to phase 3 development based on completed clinical studies and feedback received from regulatory authorities1,2PLAINSBORO, N.J.,...

Water Instead of Diet Drinks Associated with Two-Fold Rate of Diabetes Remission in Women

New Research Demonstrates Significant Benefits of Simple Dietary Switch for Blood Glucose Control and Long-Term Weight Management CHICAGO, June 20, 2025 /PRNewswire/ -- Consistently replacing...

Stem Cell-Derived Islet Therapies Shown to Reduce the Need for Injectable Insulin

Breakthrough Studies Demonstrate Stem Cell-Based Technologies as a Potential Alternative Treatment for Type 1 Diabetes CHICAGO, June 20, 2025 /PRNewswire/ -- Findings from two studies...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsContent

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers